Stock ABOS ACUMEN PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Acumen Pharmaceuticals, Inc.

Equities

ABOS

US00509G2093

Real-time Estimate Cboe BZX
Other stock markets
 09:34:02 2024-05-09 am EDT 		5-day change 1st Jan Change
3.42 USD +0.59% Intraday chart for Acumen Pharmaceuticals, Inc. +4.62% -11.46%
May. 08 Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study MT
May. 08 Acumen Pharmaceuticals, Inc. Announces First Patient Dosed in Altitude-Ad, A Phase 2 Clinical Trial of Sabirnetug in Early Alzheimer?S Disease CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ABOS Stock
  4. Revisions Acumen Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW